comparing glp-1 agonists Table 1 from Glucagon-Like Peptide-1 (GLP-1) Receptor Drug Class Review GLP-1 Agonists Transform Diabetes &
Description
Back AAAS EurekAlert (18 Dec 2023) 'Toronto study identifies new concepts for GLP-1 action in the brain, the 2023 Science magazine breakthrough of the year'
Physiol Behav (2008) 94(5):6704

Genetically predicted glucose-dependent insulinotropic polypeptide (GIP) levels and cardiovascular disease risk are driven by distinct causal variants in the GIPR region

Reducing food intake and extending satiety are significant for weight management and loss

Accordingly, they result in appetite control, energy expenditure, and metabolism regulation

Glucagon-like peptide-1(1-37) inhibits chemokine-induced migration of human CD4-positive lymphocytes
